Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,544 followers.

New research: Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors: Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs)… #oncology h

04 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.